Compare AJANTA PHARMA with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA UNICHEM LAB AJANTA PHARMA/
UNICHEM LAB
 
P/E (TTM) x 28.3 -40.3 - View Chart
P/BV x 7.0 1.0 708.5% View Chart
Dividend Yield % 0.5 1.4 35.9%  

Financials

 AJANTA PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
UNICHEM LAB
Mar-19
AJANTA PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,422292 487.0%   
Low Rs898182 493.2%   
Sales per share (Unadj.) Rs233.5167.7 139.3%  
Earnings per share (Unadj.) Rs44.0-3.6 -1,210.9%  
Cash flow per share (Unadj.) Rs52.25.9 877.8%  
Dividends per share (Unadj.) Rs9.004.00 225.0%  
Dividend yield (eoy) %0.81.7 46.0%  
Book value per share (Unadj.) Rs255.1372.3 68.5%  
Shares outstanding (eoy) m88.0270.38 125.1%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x5.01.4 351.4%   
Avg P/E ratio x26.4-65.3 -40.4%  
P/CF ratio (eoy) x22.239.9 55.7%  
Price / Book Value ratio x4.50.6 714.1%  
Dividend payout %20.5-110.2 -18.6%   
Avg Mkt Cap Rs m102,08116,680 612.0%   
No. of employees `0006.82.6 261.3%   
Total wages/salary Rs m4,3072,393 180.0%   
Avg. sales/employee Rs Th3,022.64,535.2 66.6%   
Avg. wages/employee Rs Th633.4919.8 68.9%   
Avg. net profit/employee Rs Th569.1-98.2 -579.5%   
INCOME DATA
Net Sales Rs m20,55411,801 174.2%  
Other income Rs m211984 21.4%   
Total revenues Rs m20,76512,785 162.4%   
Gross profit Rs m5,664-835 -678.4%  
Depreciation Rs m721674 107.0%   
Interest Rs m1275 15.4%   
Profit before tax Rs m5,143-600 -857.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273-343 -370.6%   
Profit after tax Rs m3,870-256 -1,514.4%  
Gross profit margin %27.6-7.1 -389.5%  
Effective tax rate %24.857.3 43.2%   
Net profit margin %18.8-2.2 -869.5%  
BALANCE SHEET DATA
Current assets Rs m11,81220,384 57.9%   
Current liabilities Rs m3,7765,029 75.1%   
Net working cap to sales %39.1130.1 30.0%  
Current ratio x3.14.1 77.2%  
Inventory Days Days77105 73.9%  
Debtors Days Days82135 60.5%  
Net fixed assets Rs m14,3989,023 159.6%   
Share capital Rs m175141 124.6%   
"Free" reserves Rs m22,27726,058 85.5%   
Net worth Rs m22,45226,199 85.7%   
Long term debt Rs m70-   
Total assets Rs m26,96231,496 85.6%  
Interest coverage x444.3-7.0 -6,370.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.4 203.5%   
Return on assets %14.4-0.6 -2,514.3%  
Return on equity %17.2-1.0 -1,767.1%  
Return on capital %23.0-2.0 -1,147.9%  
Exports to sales %069.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,6828,188 130.5%   
Fx outflow Rs m2,102596 352.7%   
Net fx Rs m8,5807,592 113.0%   
CASH FLOW
From Operations Rs m3,748-3,278 -114.3%  
From Investments Rs m-2,228-2,860 77.9%  
From Financial Activity Rs m-1,475-24 6,093.4%  
Net Cashflow Rs m45-4,690 -1.0%  

Share Holding

Indian Promoters % 73.8 50.1 147.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 15.1 10.3%  
FIIs % 7.6 3.0 253.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 31.7 53.6%  
Shareholders   20,968 20,176 103.9%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   BIOCON   WOCKHARDT  AUROBINDO PHARMA  DR. DATSONS LABS  GLENMARK PHARMA  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends at Record High; Tata Motors and Adani Ports Among Top Nifty Gainers(Closing)

Indian share markets extended gains to the second day today and ended at record-high levels with Nifty ending above 14,600-mark.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 7.2% YoY). Sales on the other hand came in at Rs 6 bn (up 18.1% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jan 20, 2021 03:36 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS